RecruitingNot ApplicableNCT07020546

Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score

Ovarian Platelet-Rich Plasma (oPRP) Injections Improvement In IVF Patients Based On Time-Lapse Incubator Culture for Automated Tracking and AI for Embryo Quality Assessment : A Non-Randomized Propsective Self-Controlled Interventional Study


Sponsor

Generation Next Fertility

Enrollment

180 participants

Start Date

Jul 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 47 Years

Inclusion Criteria3

  • No none contraindications to IVF or PRP treatment
  • Adequate ovarian reserves and AMH level
  • Willingness to undergo two IVF cycles and oPRP treatment

Exclusion Criteria2

  • Anovulation due to menopause or perimenopause
  • Any health conditions that are contraindicated for IVF or oPRP treatment

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREOvarian Platelet-rich plasma (PRP) injections

This is a procedure that our patients receive at our clinic. We want to use the AI software to evaluate embryo development before and after treatment to see if there is a difference in embryo quality after PRP treatment within the same patient.


Locations(1)

Generation Next Fertility

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07020546


Related Trials